Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06711783

Treatment of Adolescent Anorexia Nervosa

VISAN is a naturalistic study of family based treatment of Anorexia nervosa in adolescnet girls.

Recruiting

Interested in participating?

Request Info

Key information

Age range

11 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Orebro eating disorder unit

Örebro, S-70185, Sweden

Location status: Recruiting

Location contact

Sanna A Gustafsson, Ass Prof

CONTACT

[email protected]

+46722495986

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Having been diagnosed with f500 or f501 and being planned for family based therapy at the unit.

Exclusion criteria

  • being subjected to care by the social welfare system

Treatment and study plan

Family based therapy

Behavioral

Family based therapy following the Maudsley model

Primary outcomes

  1. Remission

    Time frame: End of treatment (assessed up to 1 year)

    No longer fulfilling criteria for an eating disorder

Study contacts

Contact information is provided by the study sponsor or research team.

Sanna Gustafsson A Gustafsson, Ass prof

CONTACT

[email protected]

+46722495986

Sponsors and collaborators

Lead sponsor

Region Örebro County

Other

Registry information

Official study title

VISAN - vårdkedja i Samverkan för Unga Patienter Med Anorexia Nervosa (Collaborative Chain of Care in Adolescnt Anorexia Nervosa Treatment)

Acronym: VISAN

Important dates

Study start
2024
Primary completion
2028
Study completion
2029
First posted
Dec 2, 2024
Registry last updated
May 1, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.